Review



codon-optimized rap1  (GenScript corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenScript corporation codon-optimized rap1
    VLPs characterization. MSP-8 ( A ), MSP-9 ( B ) and <t>RAP1</t> ( C ) VLP morphologies were visualized under TEM. MSP-8 ( D ), MSP-9 ( E ) and RAP1 ( F ) VLPs were loaded (8, 40 µg) for SDS-PAGE, and bands corresponding to each antigen were observed using either the polyclonal P. berghei antibody or the monoclonal M1 antibody.
    Codon Optimized Rap1, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/codon-optimized rap1/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    codon-optimized rap1 - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1"

    Article Title: Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1

    Journal: Vaccines

    doi: 10.3390/vaccines10020203

    VLPs characterization. MSP-8 ( A ), MSP-9 ( B ) and RAP1 ( C ) VLP morphologies were visualized under TEM. MSP-8 ( D ), MSP-9 ( E ) and RAP1 ( F ) VLPs were loaded (8, 40 µg) for SDS-PAGE, and bands corresponding to each antigen were observed using either the polyclonal P. berghei antibody or the monoclonal M1 antibody.
    Figure Legend Snippet: VLPs characterization. MSP-8 ( A ), MSP-9 ( B ) and RAP1 ( C ) VLP morphologies were visualized under TEM. MSP-8 ( D ), MSP-9 ( E ) and RAP1 ( F ) VLPs were loaded (8, 40 µg) for SDS-PAGE, and bands corresponding to each antigen were observed using either the polyclonal P. berghei antibody or the monoclonal M1 antibody.

    Techniques Used: SDS Page

    Experimental schedule. Mice were immunized twice with the combined VLP vaccines expressing MSP-8, MSP-9, and RAP1 of P. berghei at 4 weeks intervals, and blood samples were drawn 3 weeks after each immunization. Challenge infection was performed 4 weeks after boost immunization and half of the mice in each group were sacrificed at 1 week post-challenge.
    Figure Legend Snippet: Experimental schedule. Mice were immunized twice with the combined VLP vaccines expressing MSP-8, MSP-9, and RAP1 of P. berghei at 4 weeks intervals, and blood samples were drawn 3 weeks after each immunization. Challenge infection was performed 4 weeks after boost immunization and half of the mice in each group were sacrificed at 1 week post-challenge.

    Techniques Used: Vaccines, Expressing, Infection

    IgG antibody response. Mice were intramuscularly immunized twice with the mixture of MSP-8, MSP-9 and RAP1 VLPs. Sera ( n = 6) were collected at regular intervals after each immunization with the VLPs. VLPs immunization induced IgG antibodies reacted with P. berghei Ag ( A ) and VLPs ( B ) upon prime and boost compared to naïve sera (** P < 0.01, *** P < 0.001).
    Figure Legend Snippet: IgG antibody response. Mice were intramuscularly immunized twice with the mixture of MSP-8, MSP-9 and RAP1 VLPs. Sera ( n = 6) were collected at regular intervals after each immunization with the VLPs. VLPs immunization induced IgG antibodies reacted with P. berghei Ag ( A ) and VLPs ( B ) upon prime and boost compared to naïve sera (** P < 0.01, *** P < 0.001).

    Techniques Used:



    Similar Products

    codon-optimized rap1  (GenScript corporation)
    90
    GenScript corporation codon-optimized rap1
    VLPs characterization. MSP-8 ( A ), MSP-9 ( B ) and <t>RAP1</t> ( C ) VLP morphologies were visualized under TEM. MSP-8 ( D ), MSP-9 ( E ) and RAP1 ( F ) VLPs were loaded (8, 40 µg) for SDS-PAGE, and bands corresponding to each antigen were observed using either the polyclonal P. berghei antibody or the monoclonal M1 antibody.
    Codon Optimized Rap1, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/codon-optimized rap1/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    codon-optimized rap1 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    codon-optimized (rap1) nucleotide sequences  (GenScript corporation)
    90
    GenScript corporation codon-optimized (rap1) nucleotide sequences
    VLPs characterization. MSP-8 ( A ), MSP-9 ( B ) and <t>RAP1</t> ( C ) VLP morphologies were visualized under TEM. MSP-8 ( D ), MSP-9 ( E ) and RAP1 ( F ) VLPs were loaded (8, 40 µg) for SDS-PAGE, and bands corresponding to each antigen were observed using either the polyclonal P. berghei antibody or the monoclonal M1 antibody.
    Codon Optimized (Rap1) Nucleotide Sequences, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/codon-optimized (rap1) nucleotide sequences/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    codon-optimized (rap1) nucleotide sequences - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    VLPs characterization. MSP-8 ( A ), MSP-9 ( B ) and RAP1 ( C ) VLP morphologies were visualized under TEM. MSP-8 ( D ), MSP-9 ( E ) and RAP1 ( F ) VLPs were loaded (8, 40 µg) for SDS-PAGE, and bands corresponding to each antigen were observed using either the polyclonal P. berghei antibody or the monoclonal M1 antibody.

    Journal: Vaccines

    Article Title: Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1

    doi: 10.3390/vaccines10020203

    Figure Lengend Snippet: VLPs characterization. MSP-8 ( A ), MSP-9 ( B ) and RAP1 ( C ) VLP morphologies were visualized under TEM. MSP-8 ( D ), MSP-9 ( E ) and RAP1 ( F ) VLPs were loaded (8, 40 µg) for SDS-PAGE, and bands corresponding to each antigen were observed using either the polyclonal P. berghei antibody or the monoclonal M1 antibody.

    Article Snippet: Codon-optimized RAP1 was synthesized by GenScript.

    Techniques: SDS Page

    Experimental schedule. Mice were immunized twice with the combined VLP vaccines expressing MSP-8, MSP-9, and RAP1 of P. berghei at 4 weeks intervals, and blood samples were drawn 3 weeks after each immunization. Challenge infection was performed 4 weeks after boost immunization and half of the mice in each group were sacrificed at 1 week post-challenge.

    Journal: Vaccines

    Article Title: Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1

    doi: 10.3390/vaccines10020203

    Figure Lengend Snippet: Experimental schedule. Mice were immunized twice with the combined VLP vaccines expressing MSP-8, MSP-9, and RAP1 of P. berghei at 4 weeks intervals, and blood samples were drawn 3 weeks after each immunization. Challenge infection was performed 4 weeks after boost immunization and half of the mice in each group were sacrificed at 1 week post-challenge.

    Article Snippet: Codon-optimized RAP1 was synthesized by GenScript.

    Techniques: Vaccines, Expressing, Infection

    IgG antibody response. Mice were intramuscularly immunized twice with the mixture of MSP-8, MSP-9 and RAP1 VLPs. Sera ( n = 6) were collected at regular intervals after each immunization with the VLPs. VLPs immunization induced IgG antibodies reacted with P. berghei Ag ( A ) and VLPs ( B ) upon prime and boost compared to naïve sera (** P < 0.01, *** P < 0.001).

    Journal: Vaccines

    Article Title: Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1

    doi: 10.3390/vaccines10020203

    Figure Lengend Snippet: IgG antibody response. Mice were intramuscularly immunized twice with the mixture of MSP-8, MSP-9 and RAP1 VLPs. Sera ( n = 6) were collected at regular intervals after each immunization with the VLPs. VLPs immunization induced IgG antibodies reacted with P. berghei Ag ( A ) and VLPs ( B ) upon prime and boost compared to naïve sera (** P < 0.01, *** P < 0.001).

    Article Snippet: Codon-optimized RAP1 was synthesized by GenScript.

    Techniques:

    VLPs characterization. MSP-8 ( A ), MSP-9 ( B ) and RAP1 ( C ) VLP morphologies were visualized under TEM. MSP-8 ( D ), MSP-9 ( E ) and RAP1 ( F ) VLPs were loaded (8, 40 µg) for SDS-PAGE, and bands corresponding to each antigen were observed using either the polyclonal P. berghei antibody or the monoclonal M1 antibody.

    Journal: Vaccines

    Article Title: Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1

    doi: 10.3390/vaccines10020203

    Figure Lengend Snippet: VLPs characterization. MSP-8 ( A ), MSP-9 ( B ) and RAP1 ( C ) VLP morphologies were visualized under TEM. MSP-8 ( D ), MSP-9 ( E ) and RAP1 ( F ) VLPs were loaded (8, 40 µg) for SDS-PAGE, and bands corresponding to each antigen were observed using either the polyclonal P. berghei antibody or the monoclonal M1 antibody.

    Article Snippet: Nucleotide sequences of codon-optimized (RAP1) were obtained from GenScript, and compared with the original non-codon optimized RAP1 (XM_034565422.1) sequence acquired from NCBI database.

    Techniques: SDS Page

    Experimental schedule. Mice were immunized twice with the combined VLP vaccines expressing MSP-8, MSP-9, and RAP1 of P. berghei at 4 weeks intervals, and blood samples were drawn 3 weeks after each immunization. Challenge infection was performed 4 weeks after boost immunization and half of the mice in each group were sacrificed at 1 week post-challenge.

    Journal: Vaccines

    Article Title: Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1

    doi: 10.3390/vaccines10020203

    Figure Lengend Snippet: Experimental schedule. Mice were immunized twice with the combined VLP vaccines expressing MSP-8, MSP-9, and RAP1 of P. berghei at 4 weeks intervals, and blood samples were drawn 3 weeks after each immunization. Challenge infection was performed 4 weeks after boost immunization and half of the mice in each group were sacrificed at 1 week post-challenge.

    Article Snippet: Nucleotide sequences of codon-optimized (RAP1) were obtained from GenScript, and compared with the original non-codon optimized RAP1 (XM_034565422.1) sequence acquired from NCBI database.

    Techniques: Vaccines, Expressing, Infection

    IgG antibody response. Mice were intramuscularly immunized twice with the mixture of MSP-8, MSP-9 and RAP1 VLPs. Sera ( n = 6) were collected at regular intervals after each immunization with the VLPs. VLPs immunization induced IgG antibodies reacted with P. berghei Ag ( A ) and VLPs ( B ) upon prime and boost compared to naïve sera (** P < 0.01, *** P < 0.001).

    Journal: Vaccines

    Article Title: Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1

    doi: 10.3390/vaccines10020203

    Figure Lengend Snippet: IgG antibody response. Mice were intramuscularly immunized twice with the mixture of MSP-8, MSP-9 and RAP1 VLPs. Sera ( n = 6) were collected at regular intervals after each immunization with the VLPs. VLPs immunization induced IgG antibodies reacted with P. berghei Ag ( A ) and VLPs ( B ) upon prime and boost compared to naïve sera (** P < 0.01, *** P < 0.001).

    Article Snippet: Nucleotide sequences of codon-optimized (RAP1) were obtained from GenScript, and compared with the original non-codon optimized RAP1 (XM_034565422.1) sequence acquired from NCBI database.

    Techniques: